BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18756939)

  • 1. [Role of p16INK4a as a biomarker in liquid-based cervical cytology screening].
    Xu T; Lu HJ; He YF
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):211-4. PubMed ID: 18756939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
    Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
    Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The usefulness of p16INK4a in cytological screening of cervical carcinoma].
    Li M; Cao J; Wang NP; Li LY; Li L; Qiao YL; Pan QJ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):674-7. PubMed ID: 17274373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 6. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear.
    Bose S; Evans H; Lantzy L; Scharre K; Youssef E
    Diagn Cytopathol; 2005 Jan; 32(1):21-4. PubMed ID: 15584047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
    Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
    Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.
    Longatto Filho A; Utagawa ML; Shirata NK; Pereira SM; Namiyama GM; Kanamura CT; Santos Gda C; de Oliveira MA; Wakamatsu A; Nonogaki S; Roteli-Martins C; di Loreto C; Mattosinho de Castro Ferraz Mda G; Maeda MY; Alves VA; Syrjänen K
    Int J Gynecol Pathol; 2005 Apr; 24(2):118-24. PubMed ID: 15782067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of p16(INK4A) immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears.
    Sung CO; Kim SR; Oh YL; Song SY
    Diagn Cytopathol; 2010 Mar; 38(3):168-71. PubMed ID: 19760769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus.
    Eleutério J; Giraldo PC; Gonçalves AK; Cavalcante DI; de Almeida Ferreira FV; Mesquita SM; Morais SS
    Acta Obstet Gynecol Scand; 2007; 86(1):94-8. PubMed ID: 17230296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
    Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
    Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
    Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
    Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
    Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
    Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
    Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.